As cisplatin is known to induce apoptotic cell death [43], several studies have reported on the role of the PI3K/AKT/mTOR signaling pathway in cisplatin sensitivity/apoptosis in different cell and cancer types (e.g., kidney cells and ovarian cancer) [44–46]. This evidence concerns the gene MTOR and ovarian carcinoma.